Ranbaxy (Thailand) Co., Ltd.
Ranbaxy (Thailand) Co., Ltd., is a subsidiary of Sun Pharmaceutical Industries Ltd., the fourth largest specialty generic pharmaceutical company in the world. Our quality products are available in Thailand since 1983. Ranbaxy (Thailand) Co., Ltd is duly registered under the laws of Thailand, and permitted to conduct a trading of pharmaceutical products in Thailand under Section 17 of Foreign Business Act B.E. 2542 (1999) with the Business Permit No. 1755603100 (Registration No. 0105556033179) and carrying on service business of the Representative Office. We offer a wide range of high quality, affordable generic medicines and OTC products in a variety of dosage forms and strengths. We focus on serving the needs of our customers, patients, pharmacies and physicians. Doctors, pharmacists, and patients trust the quality of our products, which are thoroughly tested and approved.
About Sun Pharma
Sun Pharma is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in over 100 countries across the world, at affordable prices. Its global presence is supported by manufacturing facilities spread across 6 continents and approved by multiple regulatory agencies, coupled with a multi-cultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities across multiple R&D centers, with investments of approximately 7% of annual revenues in R&D. For further information, please visit www.sunpharma.com & follow us on Twitter @SunPharma_Live